Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

NCT03393884

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Mitchell Cancer Institute (University of South Alabama) Mobile, Alabama, United States

Gynecologic Oncology Associates (Hoag Hospital) Newport Beach, California, United States

Innovative Clinical Research Whittier, California, United States

View all 21 locations

View Trial Details

Active, Not Recruiting

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

NCT03482102

Conditions: Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

NCT02088645

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +14 more
Locations: University Hospital Basel, Clinic for radiology and nuclear medicine Basel, Switzerland

View Trial Details

Active, Not Recruiting

Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer

NCT01245712

Conditions: Adenocarcinoma, Breast Adenocarcinoma, Breast Carcinoma In Situ, +21 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC

NCT06519721

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China

View Trial Details

Active, Not Recruiting

Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial

NCT05531916

Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy, Carcinoma, Head and Neck Neoplasms, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma

NCT04712643

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Anhui Provincial Hospital Anhui, China

Peking University First Hospital Beijing, China

Peking University People's Hospital Beijing, China

Beijing You An Hospital Beijing, China

View all 40 locations

View Trial Details

Active, Not Recruiting

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05981131

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Island Urology Honolulu, Hawaii, United States

View Trial Details

Active, Not Recruiting

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

NCT02495896

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +39 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

View Trial Details

Active, Not Recruiting

A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma

NCT07138885

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions